SVd ranked as most valuable therapy. »
10/31/25

BRAF V600D mutation identified in tumor tissue of newborn patient. »
10/31/25

Gap in open discussions about breast density and its impact on screening accuracy. »
10/31/25

RUNX2 role in cancer plasticity and indicate metabolic adaptation. »
10/31/25

Anemia most common adverse event. »
11/01/25

Most common adverse event anemia. »
11/01/25

Intervention group demonstrated significantly lower mean scores for both stomatitis and pain. »
11/03/25

Significant upregulation of IL-3 gene in TNBC patient samples. »
11/03/25

PEAR1 induces tumor cell dormancy by binding lysyl oxidase like 2 and cathepsin D. »
11/03/25

Time to surgery has little effect on survival and mortality risk. »
11/03/25